Published in Neurosci Lett on September 07, 2008
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Sex differences in stroke. J Cereb Blood Flow Metab (2012) 1.21
Neuroprotective actions of brain aromatase. Front Neuroendocrinol (2009) 1.14
Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) (2012) 1.06
Progesterone and neuroprotection. Horm Behav (2012) 0.91
Progesterone, brain-derived neurotrophic factor and neuroprotection. Neuroscience (2012) 0.89
Diagnosis and management of catamenial seizures: a review. Int J Womens Health (2012) 0.84
Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone. Brain Res (2010) 0.83
Chronic estradiol treatment increases CA1 cell survival but does not improve visual or spatial recognition memory after global ischemia in middle-aged female rats. Horm Behav (2008) 0.82
Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model. Brain Res (2013) 0.80
Progesterone, administered before kainic acid, prevents decrements in cognitive performance in the Morris Water Maze. Dev Neurobiol (2011) 0.79
Use of estetrol with other steroids for attenuation of neonatal hypoxic-ischemic brain injury: to combine or not to combine? Oncotarget (2016) 0.78
The GABAA antagonist bicuculline attenuates progesterone-induced memory impairments in middle-aged ovariectomized rats. Front Aging Neurosci (2015) 0.77
Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats. Endocrinology (2014) 0.76
Sex and the development of Alzheimer's disease. J Neurosci Res (2017) 0.76
Effects of progesterone on hyperoxia-induced damage in mouse C8-D1A astrocytes. Brain Behav (2016) 0.75
Progesterone Protects Against Bisphenol A-Induced Arrhythmias in Female Rat Cardiac Myocytes via Rapid Signaling. Endocrinology (2017) 0.75
Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg (1997) 2.01
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Estradiol protects against ischemic injury. J Cereb Blood Flow Metab (1998) 1.98
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke (2000) 1.83
Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol (2007) 1.71
Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology (2005) 1.69
Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci (2006) 1.44
Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther (2007) 1.41
Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience (2005) 1.38
Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. Neuroreport (2004) 1.25
Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging (2001) 1.19
Estrogen effects on cognition and hippocampal transcription in middle-aged mice. Neurobiol Aging (2007) 1.19
Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res (2006) 1.17
17beta-estradiol is protective in spinal cord injury in post- and pre-menopausal rats. J Neurotrauma (2006) 1.16
Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod (1981) 1.16
Estrogens and neuroprotection. Trends Endocrinol Metab (2002) 1.15
Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience (2003) 1.11
Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol (2003) 1.10
Reproductive senescence in female rats: a longitudinal study of individual differences in estrous cycles and behavior. Biol Reprod (1988) 1.10
Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol Aging (2003) 1.08
Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience (2005) 0.93
Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. Am J Physiol Heart Circ Physiol (2004) 0.93
Estrogen and opioids interact to modulate the locomotor response to cocaine in the female rat. Brain Res (2002) 0.92
Age-related sensitivity to kainate neurotoxicity. Exp Neurol (1991) 0.92
Vulnerability of the hippocampus to kainate excitotoxicity in the aged, mature and young adult rat. Neurosci Lett (1995) 0.89
The menopause and HRT. HRT and cognitive decline. Best Pract Res Clin Endocrinol Metab (2003) 0.88
Techniques for detection of estrogenicity. Environ Health Perspect (1995) 0.87
Oestrogen and the cholinergic hypothesis: implications for oestrogen replacement therapy in postmenopausal women. Novartis Found Symp (2000) 0.85
Effects of age on gene expression during estrogen-induced synaptic sprouting in the female rat. Exp Neurol (2000) 0.85
Hormone replacement therapy: will it affect seizure control and AED levels? Seizure (2008) 0.82
Cholinergic neurons in the basal forebrain of aged female mice. Brain Res (2004) 0.79
Age-related testosterone depletion and the development of Alzheimer disease. JAMA (2004) 2.45
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci (2009) 1.88
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Comparison of fallers and nonfallers at an inpatient rehabilitation facility: a retrospective review. Rehabil Nurs (2012) 1.38
Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav (2007) 1.28
Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology (2008) 1.22
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci (2006) 1.21
Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem (2005) 1.20
Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci (2005) 1.20
Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology (2010) 1.18
Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res (2006) 1.17
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging (2009) 1.14
Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav (2012) 1.14
Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol (2009) 1.12
Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res (2010) 1.08
Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) (2012) 1.06
Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J Neurosci (2007) 1.06
Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J Neurosci (2013) 1.02
Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem (2003) 1.02
Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res (2005) 1.01
Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection. Endocrinology (2007) 0.99
Androgens, aging, and Alzheimer's disease. Endocrine (2006) 0.98
Androgens regulate neprilysin expression: role in reducing beta-amyloid levels. J Neurochem (2008) 0.97
Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease. Brain Res Rev (2007) 0.96
Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res (2010) 0.95
Conventional protein kinase C isoforms mediate neuroprotection induced by phorbol ester and estrogen. J Neurochem (2005) 0.89
The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease. Curr Alzheimer Res (2012) 0.87
Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep (2014) 0.86
Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PLoS One (2012) 0.85
Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiol Aging (2012) 0.85
17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology (2012) 0.85
Caspase activation contributes to astrogliosis. Brain Res (2012) 0.84
Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. PLoS One (2013) 0.84
Age-related changes in serum and brain levels of androgens in male Brown Norway rats. Neuroreport (2009) 0.83
Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons. Brain Res (2009) 0.83
Exercise increases the vulnerability of rat hippocampal neurons to kainate lesion. Brain Res (2003) 0.80
Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice. Brain Res (2012) 0.78
Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic protein loss in a rat Abeta-infusion Alzheimer's disease model. J Alzheimers Dis (2008) 0.77
The synthetic estrogen 4-estren-3 alpha,17 beta-diol (estren) induces estrogen-like neuroprotection. Neurobiol Dis (2005) 0.77
Deconvolution of the confounding variations for reverse transcription quantitative real-time polymerase chain reaction by separate analysis of biological replicate data. Anal Biochem (2012) 0.76
Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats. Endocrinology (2014) 0.76
Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats. Endocrinology (2014) 0.75
Multidimensional health risk appraisal among adults aging with acquired disabilities. Disabil Health J (2013) 0.75
Use of an algorithm for assessment and treatment of the upper extremity post stroke: a case study. Occup Ther Health Care (2014) 0.75
Effect of Amplification on Speech and Language in Children With Aural Atresia. Am J Audiol (2015) 0.75